Patent 11016085 was granted and assigned to Johns Hopkins University on May, 2021 by the United States Patent and Trademark Office.
The present invention describes methods of identifying drugs for the treatment or prevention of diabetes by measuring the activity of the human zinc transporter ZnT8 and pharmaceutical compositions.